AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,627,159 | +3.9% | 296,307 | +29.8% | 0.01% | +16.7% |
| Q2 2023 | $13,116,378 | +101703.6% | 228,230 | -33.6% | 0.01% | -14.3% |
| Q1 2023 | $12,884 | +371.9% | 343,560 | +252.6% | 0.01% | +250.0% |
| Q4 2022 | $2,730 | -99.3% | 97,430 | +608.1% | 0.00% | – |
| Q3 2022 | $387,000 | -86.4% | 13,760 | -83.2% | 0.00% | -100.0% |
| Q2 2022 | $2,854,000 | -54.1% | 82,041 | -52.7% | 0.00% | -33.3% |
| Q1 2022 | $6,222,000 | +265.1% | 173,321 | +136.8% | 0.00% | +200.0% |
| Q4 2021 | $1,704,000 | -54.5% | 73,181 | -62.8% | 0.00% | -50.0% |
| Q3 2021 | $3,744,000 | +1024.3% | 196,938 | +1092.8% | 0.00% | – |
| Q2 2021 | $333,000 | -84.8% | 16,510 | -86.2% | 0.00% | -100.0% |
| Q1 2021 | $2,193,000 | -39.3% | 119,695 | -33.4% | 0.00% | -33.3% |
| Q4 2020 | $3,614,000 | +51.2% | 179,693 | +41.0% | 0.00% | 0.0% |
| Q3 2020 | $2,390,000 | +142.6% | 127,465 | +190.8% | 0.00% | +200.0% |
| Q2 2020 | $985,000 | -8.3% | 43,834 | -19.1% | 0.00% | -50.0% |
| Q3 2019 | $1,074,000 | +244.2% | 54,180 | +266.3% | 0.00% | – |
| Q2 2019 | $312,000 | -25.7% | 14,791 | -28.0% | 0.00% | -100.0% |
| Q1 2019 | $420,000 | -85.0% | 20,537 | -85.4% | 0.00% | -75.0% |
| Q4 2018 | $2,796,000 | +72.0% | 140,507 | +66.3% | 0.00% | +100.0% |
| Q3 2018 | $1,626,000 | +176.5% | 84,506 | +119.4% | 0.00% | +100.0% |
| Q2 2018 | $588,000 | -28.1% | 38,520 | -11.7% | 0.00% | 0.0% |
| Q1 2018 | $818,000 | -85.5% | 43,626 | -85.1% | 0.00% | -87.5% |
| Q4 2017 | $5,650,000 | +1889.4% | 293,672 | +1746.9% | 0.01% | – |
| Q3 2017 | $284,000 | -4.7% | 15,901 | -4.8% | 0.00% | -100.0% |
| Q2 2017 | $298,000 | -36.6% | 16,701 | -57.3% | 0.00% | 0.0% |
| Q1 2016 | $470,000 | -76.1% | 39,142 | -71.6% | 0.00% | -75.0% |
| Q4 2015 | $1,963,000 | +199.7% | 137,949 | +146.2% | 0.00% | +300.0% |
| Q3 2015 | $655,000 | -69.6% | 56,037 | -54.4% | 0.00% | -75.0% |
| Q2 2015 | $2,158,000 | +70.7% | 122,772 | +45.3% | 0.00% | +100.0% |
| Q1 2015 | $1,264,000 | +311.7% | 84,475 | +219.7% | 0.00% | +100.0% |
| Q4 2014 | $307,000 | – | 26,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |